Metformin treatment reduced the cell viability in human ACTH-secreting adenomas and non-functioning adenomas, not so in GH-secreting and prolactin-secreting tumors, and did not affect hormone secretion, despite the high concentration used [35]. The gene discussed is PRL; the disease is adenoma.